CyberKnife treatment in Turkey: Process, indications & clinical outcomes

What is Cyberknife treatment?

Looking for a non-surgical approach to target your tumor? CyberKnife represents a major advancement in radiation oncology. This stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system delivers highly targeted radiation directly to the lesion while reducing exposure to surrounding healthy tissues.

Unlike traditional radiosurgery, CyberKnife tracks tumor shape and body movement in real time, enabling the treatment of complex or delicate areas, such as the brain, spine, or spinal cord. For patients considered inoperable or facing surgical risks, it provides an additional therapeutic option.

Key aspects of CyberKnife treatment in Turkey include:

• Non-invasive procedure: Delivery is typically painless during the session, though some patients may experience mild pressure or positioning discomfort. Because it requires no surgical incisions, it supports a faster return to daily activities. However, temporary post-treatment discomfort or side effects may occur depending on the targeted region.
• High precision: Sub-millimeter targeting helps protect critical adjacent structures.
• Personalized treatment: Multidisciplinary oncology teams tailor each protocol to the patient's individual clinical profile.

Consult with our medical specialists in Turkey to evaluate your diagnosis and explore whether CyberKnife is suitable for your treatment plan.

CyberKnife cancer treatment: Applicable cases

CyberKnife treatment is a versatile, non-invasive option suitable for various areas of the body where radiation therapy is effective. It can target both malignant (cancerous) and benign (non-cancerous) growths, as well as metastatic tumors, arteriovenous malformations, and certain functional conditions. Patients should always consult with their doctor to determine if CyberKnife aligns with their specific medical needs.

This treatment is particularly effective for:

• Brain tumors (primary or secondary) and tumors of the head and neck regions.
• Spinal tumors affecting vertebrae or surrounding tissue.
• Soft tissue tumors in organs such as the lungs, liver, kidneys, and pancreas.
• Specific conditions like acoustic neuromas, meningiomas, skull base tumors, and pituitary tumors.
• Eye cancers and recurrent or residual tumors.
• Arteriovenous malformations.
• Certain functional disorders, including trigeminal neuralgia.
• Prostate cancer.

With its precision and adaptability, CyberKnife can treat tumors in delicate or difficult-to-reach locations, offering patients a safe, effective, and personalized approach.

Discover if CyberKnife treatment is suitable for your condition. Consult our specialists in Turkey for a personalized evaluation and treatment plan.

How does the CyberKnife therapy session proceed?

A typical session of Cyberknife therapy involves several key steps:

Imaging exam

A computed tomography (CT),magnetic resonance imaging (MRI),angiography, or PET scan is performed before the initial radiation treatment to precisely identify the size, shape, and placement of the target area. This information is utilized to create the treatment planning strategy and to define the "radiation field," or the area that the rays should target.

Treatment planning

The imaging data is sent to the treatment planning system, where a trained medical doctor identifies:

• The tumor to target
• Nearby critical structures to protect
• The radiation dose required
• The number of sessions (usually 1–5)

Using this information, a medical physicist designs the most effective and safe treatment strategy tailored to the patient's unique condition.

CyberKnife system for treatment

Treatment usually begins about one week after planning. Patients lie on the treatment couch while the robotic CyberKnife system navigates around them, delivering precisely targeted radiation to the tumor. Radiation delivery itself is typically painless, non-invasive, and does not require general anesthesia. However, patients may experience mild positioning discomfort during the session, and temporary side effects or post-treatment discomfort may develop afterward depending on the treated area.

Benefits of CyberKnife treatment

With the support of advanced stereotactic technology, CyberKnife offers several distinct characteristics compared to conventional radiation therapy:

• Shorter treatment schedule: CyberKnife protocols are typically completed in 1 to 5 targeted sessions, compared to several weeks for conventional external beam radiation.
• Outpatient delivery: The procedure is non-invasive and requires no surgical immobilization frames; patients remain comfortably positioned on the treatment couch during exposure.
• Personalized targeting: Multidisciplinary oncology teams tailor the radiation plan to the precise dimensions, shape, and real-time movement of the tumor.
• Preserves healthy cells: The system's sub-millimeter precision allows high-dose radiation delivery directly to the lesion while significantly minimizing damage to surrounding healthy tissues.

CyberKnife vs. conventional radiotherapy

Here's how the two approaches stack up:

In practice, that level of precision means treatment wraps up faster and stays more concentrated, usually with fewer complications and a better quality of life throughout care.

Reach out to our team to find out if CyberKnife is a good fit for your case, and get a free, personalized quote for your medical trip to Turkey.

What CyberKnife technology is used in Turkey?

Turkey's specialized centers mainly rely on the CyberKnife M6 by Accuray, one of the most advanced systems available in robotic radiosurgery today.

What that actually means for you:

• Sub-millimeter precision.
• A robotic arm that can shift treatment angles on the fly.
• Real-time tracking of your breathing throughout the session.
• No rigid head frame, no surgery involved.

The system delivers tightly targeted radiation doses with remarkable accuracy, often in just a handful of sessions, and typically without a long hospital stay.

CyberKnife M6 in Turkey: What the clinical results show

Turkish centers work predominantly with the CyberKnife M6, widely regarded as one of the top-performing robotic radiotherapy platforms in the world.

Here's what published medical research shows:

• Prostate cancer (SBRT): Over 90% recurrence-free survival at 5 years in low-risk patients, with serious complications remaining rare.
• Inoperable lung cancer: 92% local control, along with 74% overall survival at 2 years.
• Brain metastases: Around 92% local control at 3 months, and close to 79% overall survival at the same point.
• Liver cancer: Roughly 85% local control at 1–2 years, with minimal side effects.

Medical sources & references

The information on CyberKnife here draws from peer-reviewed studies and validated clinical outcomes. Main sources consulted:

• Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer: Long-Term Outcomes—covers 5-year recurrence-free survival rates and low toxicity in prostate SBRT.
• Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer—looks at local control and overall survival following CyberKnife treatment for inoperable lung cancer.
• CyberKnife Radiosurgery for Brain Metastases: Clinical Outcomes and Safety—reports on local control and survival outcomes for brain metastasis patients.
• Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Local Control and Toxicity—evaluates local control and side effects in patients with inoperable liver cancer.